LigoCyte Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

LigoCyte Pharmaceuticals Ownership

Who owns LigoCyte Pharmaceuticals?

LigoCyte Pharmaceuticals is owned by Takeda Pharmaceutical. It was acquired on October 4, 2012.

Was LigoCyte Pharmaceuticals formerly PE-backed?

Yes. LigoCyte Pharmaceuticals was formerly owned by 1 private investor.

LigoCyte Pharmaceuticals Business Overview

Where is LigoCyte Pharmaceuticals headquartered?

LigoCyte Pharmaceuticals is headquartered in Bozeman, Montana.

What sector is LigoCyte Pharmaceuticals in?

LigoCyte Pharmaceuticals is a life science company.

When was LigoCyte Pharmaceuticals founded?

LigoCyte Pharmaceuticals was founded in 1998.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

LigoCyte Pharmaceuticals

LigoCyte Pharmaceuticals, Inc.

2155 Analysis Drive,
Bozeman, Montana 59718
United States,
(406) 585-2733
www.ligocyte.com

LigoCyte Pharmaceuticals is a privately-held biopharmaceutical company specializing in innovative vaccine products. Its lead product, a vaccine to prevent norovirus gastroenteritis, is in phase I/II of clinical development. LigoCyte Pharmaceuticals was founded in 1998 and is based in Bozeman, Montana.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.